RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Guangdi Wang to Aromatase Inhibitors

Back to Details
This is a "connection" page, showing publications Guangdi Wang has written about Aromatase Inhibitors.
Guangdi Wang
Connection Strength
0.113
Aromatase Inhibitors
  1. Jiang Q, Zheng S, Wang G. Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer. Future Med Chem. 2013 Jun; 5(9):1023-35.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support